Budesonide Orodispersible Tablets are Highly Effective for Treatment of Active Eosinophilic Esophagitis: Results from a Randomized, Double-Blind, Placebo-Controlled, Pivotal Multicenter Trial (EOS-1)Alfredo J. Lucendo, Alex Straumann, Constanza Ciriza de los Ríos et al.|Gastroenterology|2017Cited by 13
951a – Budesonide Orodispersible Tablets are Highly Effective to Maintain Clinico-Histological Remission in Adult Patients with Eosinophilic Esophagitis: Results from the 48-Weeks, Double-Blind, Placebo-Controlled, Pivotal Eos-2 TrialAlfredo J. Lucendo, Alex Straumann, Stephan Miehlke et al.|Gastroenterology|2019Cited by 10
309 - Prolongation of Eosinophilic Esophagitis Treatment with Budesonide Orodispersible Tablets for Incomplete Responder is Effective and Safe: Results from a 6-Weeks Open-Label Treatment Phase of the Pivotal Trial EOS-1Alfredo J. Lucendo, Alex Straumann, Stephan Miehlke et al.|Gastroenterology|2018Cited by 3
Sa1145 - Predictors for Early Versus Delayed Response to Budesonide Orodispersible Tablets in Eosinophilic Esophagitis Treatment: A Subgroup Analysis from the Pivotal Trial Eos-1Alex Straumann, Alfredo J. Lucendo, Roland Greinwald et al.|Gastroenterology|2018Cited by 2